FWFeng Wang

Feng Wang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Feng Wang has a total of 10 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Systemic release of high mobility group box 1 (HMGB1) protein is associated with severe and fatal Plasmodium falciparum malaria

    by Sarah J Higgins, Katharine Xing, Hani Kim, Dylan C Kain, Feng Wang, Aggrey Dhabangi, Charles Musoke, Christine M Cserti-Gazdewich, Kevin J Tracey, Kevin C Kain, et al.

    Background: Severe falciparum malaria (SM) pathogenesis has been attributed, in part, to deleterious systemic host inflammatory responses to infection. High mobility group box 1 (HMGB1) protein is an important mediator of inflammation implicated in sepsis pathophysiology.Methods: Plasma levels of HMGB1 were quantified in a cohort of febrile Ugandan children withPlasmodium falciparuminfection, enrolled in a prospective observational case-controlled study, using a commercial enzyme-linked immunosorbent assay. The utility of HMGB1 to distinguish severe malaria (SM; n = 70) from uncomplicated malaria (UM; n = 33) patients and fatal (n = 21)versusnon-fatal (n = 82) malaria, at presentation, was examined. Receiver operating characteristic curve analysis was used to assess the prognostic accuracy of HMGB1. The ability ofP. falciparum-parasitized erythrocytes to induce HMGB1 from peripheral blood mononuclear cells was assessedin vitro. The effect of an anti-HMGB1 neutralizing antibody on disease outcome was assessed in the experimentalPlasmodium bergheiANKA rodent parasite model of SM. Mortality and parasitaemia was assessed daily and compared to isotype antibody-treated controls.Results: Elevated plasma HMGB1 levels at presentation were significantly associated with SM and a subsequent fatal outcome in paediatric patients withP. falciparuminfection.In vitro, parasitized erythrocytes induced HMGB1 release from human peripheral blood mononuclear cells. Antibody-mediated neutralization of HMGB1 in the experimental murine model of severe malaria failed to reduce mortality.Conclusion: These data suggest that elevated HMGB1 is an informative prognostic marker of disease severity in human SM, but do not support HMGB1 as a viable target for therapeutic intervention in experimental murine SM.